Appili Therapeutics Inc (APLI) — Cash Flow Reinvestment Rate

Latest as of March 2025: 0.00x

Appili Therapeutics Inc (APLI) has a Cash Flow Reinvestment Rate of 0.00x as of March 2025, reinvesting CA$2.36K (capex CA$2.36K ) from operating cash flow of CA$1.03 Million. Check APLI cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

CA$2.36K

Capex + Investments

Operating Cash Flow

CA$1.03 Million

CAD

Capital Expenditures

CA$2.36K

CAD

Appili Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)

Historical reinvestment intensity for Appili Therapeutics Inc across 1 annual periods. Explore APLI operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Appili Therapeutics Inc (2025–2025)

Year-by-year capital reinvestment analysis for Appili Therapeutics Inc. For live market cap and broader valuation context, see APLI stock market capitalisation.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2025	0.01x	CA$4.72K	CA$868.82K	CA$2.36K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow